EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Risk Management in the U.S. Pharmaceutical Industry: Supply, Manufacturing and Regulatory Resilience
US pharma risk management is the practice of identifying scoring and reducing threats to drug quality supply and compliance before they reach patients The strongest programs focus on three areas supply chain risk sourcing logistics shortages manufacturing risk quality contamination capacity and regulatory risk FDA inspections data integrity policy shifts They connect
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
AZP2006 in Parkinson’s disease models: A promising new neuroprotective treatment involving lysosomal homeostasis and the Progranulin/Prosaposin complex
The pathohistological hallmarks of Parkinsons disease are aggregated alphasynuclein and other aggregationprone proteins Lewy bodies Recent studies show mechanistic as well as genetic connections between lysosomal dysfunction and Parkinsons disease pathology A direct link between lysosomal function and Parkinsons disease might be the degradation of alphasynuclein within the lysosomal system
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Innovative Therapies: How Cell and Gene Technologies are Changing Lives
Kate Williamson
Medical science stands transformed through pioneering advancements in cell and gene therapy which treat chronic diseases and genetic conditions at their foundations. Through genome-editing technologie...
-
2
U.S. Cell and Gene Therapy Market: How Pharma Is Scaling Up
Lakshmi
The U.S. cell and gene therapy market is moving from bespoke, center-by-center breakthroughs toward industrial-scale medicine. This article examines how pharma is scaling up: an advanced-therapy pipel...
-
3
Role of Medical Affairs in HCP Engagement: Effective Strategies and Tools for Success
Kate Williamson
The changing healthcare ecosystem has enhanced the significance of Medical Affairs in achieving meaningful engagement of HCPs. In this article, the authors will discuss how strategic communication, di...
-
4
Unlocking the Power of Biomarkers: A Comprehensive Guide
Kate Williamson
Biomarkers, spanning genes, proteins, and imaging features, are pivotal in healthcare, offering insights into disease, personalized treatment, and drug development. Challenges include standardization...
-
5
10 Reasons to Consider Placebo Use in Clinical Trials
Kate Williamson
Clinical trials are pivotal for medical advancements, and the use of placebos is a critical element. This exploration outlines ten reasons for the essential role of placebos, emphasizing their contrib...
press releasesRead more...
Repligen completes acquisition of BioLife Solutions
Repligen Corporation NASDAQ RGEN Repligen or the Company a life sciences company focused on bioprocessing technology leadership today announced it has completed the previously announced
Electron Bio Launches FAST GMP™ Modular Cleanroom Platform and FAST QMS™
Electron Bio today launched FAST GMP its patentpending modular cleanroom platform for cGMP manufacturing together with FAST QMS and CMC services Electron Bio conceived and designed
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
ORIC Pharmaceuticals Inc Nasdaq ORIC a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
Pacira BioSciences Inc NASDAQ PCRX the industry leader in its commitment to deliver innovative nonopioid pain therapies to transform the lives of patients today announced a strategic partnership with Molteni
Events Read more...
12 - 14
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026PM& AC 2026
Novotel Hyderabad Convention C...
LATEST NEWSRead more...
Americhem Opens New Clean Compounding Facility in Suzhou, China
Americhem a global leader in custom polymer solutions celebrated the opening of its new clean compounding facility in Suzhou on September The investment expands Americhems ability to support customers in China across AsiaPacific and around the world who manufacture in the region
GCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration
GCCL a South Koreabased leading global clinical trial central laboratory represented by CEO Kwangoo Cho announced today that it signed a Memorandum of Understanding MOU with LabConnect on October to expand global clinical trial collaboration LabConnect is a global central laboratory and clinical tr...
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
PacBio and TychoBio have announced a collaboration to generate fulllength RNA data for training artificial intelligence AI models that support the design of RNA therapies for rare diseases
Relay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease Programmes
Relay Network and Claritas Rx have announced a strategic partnership to help life sciences companies improve patient access support and treatment adherence across specialty and rare disease programmes
Psyence BioMed Partners with Benuvia to Establish U.S. Manufacturing of Pharmaceutical-Grade Ibogaine
Psyence Biomedical Ltd Nasdaq PBM through its wholly owned Texas subsidiary Texas Ibogaine Research Corporation TIRC has entered into a manufacturing services agreement with Benuvia Operations
Italfarmaco and VeriSIM Life Partner to Develop HDAC-Targeted Therapies for Neuromuscular and Rare Diseases
Italfarmaco SpA and VeriSIM Life have entered into a strategic collaboration to discover and develop novel histone deacetylase HDACtargeted therapies for neuromuscular fibrotic and rare diseases
